Free
IlÚM Engage
⭐️0 / 5
Rating
🙌0
Ratings
📼4 scs
Content
📦~ in 2 months
Updates frequency
🗣❌ unsupported
Your locale
- Versions
- Price History
- Description
- FAQ
All Versions of IlÚM Engage
1.0.8
May 21, 2024
Bulk Archiving feature!
1.0.7
March 26, 2024
- Whitespace stripping on username when logging in.
- Disabling weekend push notification
More1.06
December 8, 2023
- Bug fixes
- Added support for cell phone number display
- Added support for services / facilities not in coverage hours
More1.0.5
May 3, 2023
- Fix for resetting password
1.0
April 11, 2023
Price History of IlÚM Engage
Description of IlÚM Engage
ILÚM Engage, created by Infectious Disease Connect (IDC), is a telehealth app that keeps clinicians connected with Infectious Disease (ID) support. It provides a quick way to request consults for patients without the need for telephonic or electronic medical record (EMR) interactions. ILÚM Engage users will be able to easily:
Request ID consults from IDC clinicians
Identify consults as high or standard priority
Provide updates on existing requests
Check the status of existing consults
Keep track of historical consults
Filter requests by health care facilities
Show less
IlÚM Engage: FAQ
No, the IlÚM Engage software is not iPad-compatible.
The IlÚM Engage app was created by Infectious Disease Connect, Inc..
The IlÚM Engage app requires iOS 11.0 or later.
IlÚM Engage has no ratings yet.
Medical Is The Primary Genre Of The Ilúm Engage App.
1.0.8 is the newly released version of the IlÚM Engage app.
The date of the last IlÚM Engage update is July 6, 2024.
The IlÚM Engage app was initially released on July 3, 2024.
The content advisory rating is Infectious Disease Connect, Inc.: The IlÚM Engage app is unsuitable for persons under 17 years of age.
IlÚM Engage currently features the following languages: American English.
Unfortunately, IlÚM Engage is not on Apple Arcade.
Unfortunately, in-app purchases are not part of IlÚM Engage.
Unfortunately, IlÚM Engage is not tailored for compatibility with Apple Vision Pro.
